Deep Track Capital »

Verastem shares owned by Deep Track Capital

Quarter-by-quarter ownership of Verastem (VSTM) shares owned by Deep Track Capital from 13F filings

Historical chart of Deep Track Capital investment in Verastem

Tip: Access up to 7 years of quarterly data

All positions including Verastem held by Deep Track Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verastem by Deep Track Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $44M 5.7M 7.72

More positions owned by Deep Track Capital

Spdr Series Trust State Street Spd Put Option (XBI)
Immunovant (IMVT)
Guardant Health (GH)
Structure Therapeutics Sponsored Ads (GPCR)
Tarsus Pharmaceuticals (TARS)
Dynavax Technologies Corp Com New (DVAX)
Cytokinetics Com New (CYTK)
Axsome Therapeutics (AXSM)
Apellis Pharmaceuticals (APLS)
Vaxcyte (PCVX)
Maze Therapeatics (MAZE)
Vera Therapeutics Cl A (VERA)
BioMarin Pharmaceutical (BMRN)
Ionis Pharmaceuticals (IONS)
Nurix Therapeutics (NRIX)

View all positions for Deep Track Capital

Top funds holding Verastem

Rtw Investments
Deep Track Capital
BlackRock
Vanguard Group
Balyasny Asset Management
Polar Capital Holdings
State Street Corporation
Stonepine Capital Management
Foresite Capital Management VI
Armistice Capital
Farallon Capital Management
Rosalind Advisors
Logos Global Management
Goldman Sachs Group
Geode Capital Management

View all funds holding Verastem